These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 11072506)

  • 41. Long-term event-free survivors after high-dose therapy and autologous stem-cell transplantation for low-grade follicular lymphoma.
    Andreadis C; Schuster SJ; Chong EA; Svoboda J; Luger SM; Porter DL; Tsai DE; Nasta SD; Elstrom RL; Goldstein SC; Downs LH; Mangan PA; Cunningham KA; Hummel KA; Gimotty PA; Siegel DL; Glatstein E; Stadtmauer EA
    Bone Marrow Transplant; 2005 Dec; 36(11):955-61. PubMed ID: 16205727
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Nonmyeloablative stem cell transplantation is an effective therapy for refractory or relapsed hodgkin lymphoma: results of a spanish prospective cooperative protocol.
    Alvarez I; Sureda A; Caballero MD; Urbano-Ispizua A; Ribera JM; Canales M; García-Conde J; Sanz G; Arranz R; Bernal MT; de la Serna J; Díez JL; Moraleda JM; Rubió-Félix D; Xicoy B; Martínez C; Mateos MV; Sierra J
    Biol Blood Marrow Transplant; 2006 Feb; 12(2):172-83. PubMed ID: 16443515
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Standard versus alternative myeloablative conditioning regimens in allogeneic hematopoietic stem cell transplantation for high-risk acute leukemia.
    Mengarelli A; Iori A; Guglielmi C; Romano A; Cerretti R; Torromeo C; Micozzi A; Fenu S; Laurenti L; Donato V; De Felice L; Arcese W
    Haematologica; 2002 Jan; 87(1):52-8. PubMed ID: 11801465
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Sequential intensified conditioning and tapering of prophylactic immunosuppressants for graft-versus-host disease in allogeneic hematopoietic stem cell transplantation for refractory leukemia.
    Liu QF; Fan ZP; Zhang Y; Jiang ZJ; Wang CY; Xu D; Sun J; Xiao Y; Tan H
    Biol Blood Marrow Transplant; 2009 Nov; 15(11):1376-85. PubMed ID: 19822296
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Transplantation for non-Hodgkin lymphoma.
    Nademanee A
    Expert Rev Hematol; 2009 Aug; 2(4):425-42. PubMed ID: 21082947
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Graft-versus-lymphoma effect after reduced intensity allogeneic hematopoietic stem cell transplantation from HLA-two loci mismatched father in a patient with refractory non-Hodgkin lymphoma.
    Suminoe A; Matsuzaki A; Koga Y; Hatano M; Hara T; Hara T
    Turk J Pediatr; 2009; 51(5):500-3. PubMed ID: 20112609
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Ten-year follow-up of pediatric patients with non-Hodgkin lymphoma treated with allogeneic or autologous stem cell transplantation.
    Giulino-Roth L; Ricafort R; Kernan NA; Small TN; Trippett TM; Steinherz PG; Prockop SE; Scaradavou A; Chiu M; O'Reilly RJ; Boulad F
    Pediatr Blood Cancer; 2013 Dec; 60(12):2018-24. PubMed ID: 24038967
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Second hematopoietic SCT for lymphoma patients who relapse after autotransplantation: another autograft or switch to allograft?
    Freytes CO; Lazarus HM
    Bone Marrow Transplant; 2009 Nov; 44(9):559-69. PubMed ID: 19701250
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Pretransplantation [18-F]fluorodeoxyglucose positron emission tomography scan predicts outcome in patients with recurrent Hodgkin lymphoma or aggressive non-Hodgkin lymphoma undergoing reduced-intensity conditioning followed by allogeneic stem cell transplantation.
    Dodero A; Crocchiolo R; Patriarca F; Miceli R; Castagna L; Ciceri F; Bramanti S; Frungillo N; Milani R; Crippa F; Fallanca F; Englaro E; Corradini P
    Cancer; 2010 Nov; 116(21):5001-11. PubMed ID: 20665491
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Allogeneic stem cell transplantation in mantle cell lymphoma: where are we now and which way should we go?
    Le Gouill S; Mohty M; Guillaume T; Gastinne T; Moreau P
    Semin Hematol; 2011 Jul; 48(3):227-39. PubMed ID: 21782065
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Stem-cell transplantation for indolent lymphoma.
    Gribben JG
    Semin Hematol; 1999 Oct; 36(4 Suppl 5):18-25. PubMed ID: 10528912
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Hematopoietic stem cell transplantation for non-Hodgkin lymphoma.
    Bhatt VR; Vose JM
    Hematol Oncol Clin North Am; 2014 Dec; 28(6):1073-95. PubMed ID: 25459180
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Allogeneic or autologous stem cell transplantation (SCT) for relapsed and refractory Hodgkin's disease and non-Hodgkin's lymphoma: a single-centre experience.
    Nachbaur D; Oberaigner W; Fritsch E; Nussbaumer W; Gastl G
    Eur J Haematol; 2001 Jan; 66(1):43-9. PubMed ID: 11168507
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Allogeneic hematopoietic stem cell transplantation for non-Hodgkin's lymphomas: a retrospective analysis of 77 cases.
    Picleanu AM; Novelli S; Monter A; Garcia-Cadenas I; Caballero AC; Martino R; Esquirol A; Briones J; Sierra J
    Ann Hematol; 2017 May; 96(5):787-796. PubMed ID: 28168350
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [Therapy of low-grade non-Hodgkin lymphomas].
    Hiddemann W; Unterhalt M; Wörmann B
    Praxis (Bern 1994); 1996 Mar; 85(12):357-63. PubMed ID: 8643898
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Allogeneic bone marrow transplantation for lymphoma.
    Bierman PJ
    Blood Rev; 2000 Mar; 14(1):1-13. PubMed ID: 10805257
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Allogeneic stem cell transplantation for mantle cell lymphoma--final report from the prospective trials of the East German Study Group Haematology/Oncology (OSHO).
    Krüger WH; Hirt C; Basara N; Sayer HG; Behre G; Fischer T; Grobe N; Maschmeyer G; Niederwieser D; Dölken G
    Ann Hematol; 2014 Sep; 93(9):1587-97. PubMed ID: 24782119
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Allogeneic versus autologous bone marrow transplantation for refractory and recurrent low-grade non-Hodgkin's lymphoma: updated results of the Utrecht experience.
    Verdonck LF
    Leuk Lymphoma; 1999 Jun; 34(1-2):129-36. PubMed ID: 10350340
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Allogeneic hematopoetic stem cell transplant for patients with refractory T-Cell lymphomas.
    Massoud R; Naim H; Klyuchnikov E; Janson D; Wolschke C; Ayuk F; Kröger N
    Eur J Haematol; 2024 Feb; 112(2):276-285. PubMed ID: 37845834
    [TBL] [Abstract][Full Text] [Related]  

  • 60.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.